Evidence map›Paper›PMID 33142833›Full record

ReviewToxins2020

Sialorrhea in Parkinson's Disease.

Jonathan Isaacson, Sanskruti Patel, Yasar Torres-Yaghi, Fernando Pagán

Open access · goldAbstract readReview
In one paragraph

Review in Toxins, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 28 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
28citing papers in PubMed, 2 pooled it
2.4field-weighted citation impact, top 8% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

28 citing papers in PubMed, 2 syntheses or guidelines pooled it, 61 citations in OpenAlex.

  1. Guideline
  2. Pooled it
  3. Trial
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Review
  10. Review
  11. Review
  12. Article
  13. Pan-Gut Dysmotility in Parkinson Disease.Gastroenterology & hepatology · 2025
    Article
  14. Redefining Non-Motor Symptoms in Parkinson's Disease.Journal of personalized medicine · 2025
    Review
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 2 institutions in 1 country.

Jonathan IsaacsonDepartment of Neurology, Medstar Georgetown University Hospital, 2800 Reservoir Rd., NW Washington, D.C., WA 20007, USA.
Sanskruti PatelDepartment of Neurology, Medstar Georgetown University Hospital, 2800 Reservoir Rd., NW Washington, D.C., WA 20007, USA.
Yasar Torres-YaghiDepartment of Neurology, Medstar Georgetown University Hospital, 2800 Reservoir Rd., NW Washington, D.C., WA 20007, USA.
Fernando PagánDepartment of Neurology, Medstar Georgetown University Hospital, 2800 Reservoir Rd., NW Washington, D.C., WA 20007, USA.
Georgetown University · USMedStar Georgetown University Hospital · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Sialorrhea, or excessive saliva beyond the margin of the lip, is a common problem in many neurological diseases. Previously, sialorrhea has been underrecognized in Parkinson's disease (PD) patients. Despite this, many patients rank sialorrhea as one of the most debilitating complaints of Parkinson's disease. Previous treatment for sialorrhea has been suboptimal and has been plagued by significant side effects that are bothersome and can be dangerous in patients with a concurrent neurodegenerative disease. This review sought to review the anatomy, function, and etiology of sialorrhea in PD. It then sought to examine the evidence for the different treatments of sialorrhea in PD, and further examined newer evidence for safety and efficacy in minimally invasive treatment such as botulinum toxin.

Indexed as

SalivationAcetylcholine Release InhibitorsAnimalsBotulinum Toxins, Type AHumansParkinson DiseaseSalivary GlandsSialorrheaTreatment OutcomeabobotulinumtoxinAAcetylcholine Release InhibitorsBotulinum Toxins, Type AincobotulinumtoxinArimabotulinumtoxinBAbobotulinumtoxin Abotulinum toxindroolingIncobotulinumtoxin AOnabotulinumtoxin AParkinson’s diseaseRimabotulinumtoxin Bsialorrhea

Identifiers

PMID33142833
PMCPMC7692771
OpenAlexW3097858694

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.